AU1997795A - Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions - Google Patents

Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions

Info

Publication number
AU1997795A
AU1997795A AU19977/95A AU1997795A AU1997795A AU 1997795 A AU1997795 A AU 1997795A AU 19977/95 A AU19977/95 A AU 19977/95A AU 1997795 A AU1997795 A AU 1997795A AU 1997795 A AU1997795 A AU 1997795A
Authority
AU
Australia
Prior art keywords
ulcerations
thalidomide
lesions
topical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19977/95A
Other languages
English (en)
Inventor
Daniel J. Piacquadio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DERMCO DEVELOPMENT LP
Original Assignee
DANIEL J PIACQUADIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DANIEL J PIACQUADIO filed Critical DANIEL J PIACQUADIO
Publication of AU1997795A publication Critical patent/AU1997795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19977/95A 1994-03-14 1995-03-14 Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions Abandoned AU1997795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US212520 1994-03-14
US08/212,520 US5443824A (en) 1994-03-14 1994-03-14 Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
PCT/US1995/003162 WO1995024891A1 (fr) 1994-03-14 1995-03-14 Compositions topiques de thalidomide s'utilisant pour des blessures, des ulcerations et des lesions superficielles ou des muqueuses

Publications (1)

Publication Number Publication Date
AU1997795A true AU1997795A (en) 1995-10-03

Family

ID=22791369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19977/95A Abandoned AU1997795A (en) 1994-03-14 1995-03-14 Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions

Country Status (3)

Country Link
US (2) US5443824A (fr)
AU (1) AU1997795A (fr)
WO (1) WO1995024891A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
US6228879B1 (en) 1997-10-16 2001-05-08 The Children's Medical Center Methods and compositions for inhibition of angiogenesis
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5443824A (en) * 1994-03-14 1995-08-22 Piacquadio; Daniel J. Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
US5643915A (en) * 1995-06-06 1997-07-01 Andrulis Pharmaceuticals Corp. Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
EP0914123A4 (fr) * 1996-05-29 2000-10-11 Prototek Inc Prodrogues du thalidomide et procedes d'utilisation desdites prodrogues comme modificateurs de cellule t
DK1586322T3 (da) * 1996-11-05 2008-12-01 Childrens Medical Center Sammensætninger indeholdende thalidomid og dextamethason til behandling af cancer
EP0893122A1 (fr) * 1997-07-25 1999-01-27 Ferdinando Ippolito Compositions topiques contenant du talidomide et leur utilisation dans les pathologies cutanées
US6638949B1 (en) * 1997-08-25 2003-10-28 Judah Folkman Prevention of adhesions and excessive scar formation using angiogenesis inhibitors
ATE269699T1 (de) * 1997-10-31 2004-07-15 Childrens Medical Center Methoden zur regulierung der grösse und des wachstums von durchblutetem normalem gewebe
US6673828B1 (en) 1998-05-11 2004-01-06 Children's Medical Center Corporation Analogs of 2-Phthalimidinoglutaric acid
US6204270B1 (en) * 1999-11-12 2001-03-20 Eyal S. Ron Ophthalmic and mucosal preparations
US20010041716A1 (en) * 1999-12-02 2001-11-15 Laing Timothy J. Compositions and methods for locally treating inflammatory diseases
US20080233050A1 (en) * 2000-01-18 2008-09-25 Mallinckrodt Inc. Diagnostic and therapeutic optical agents
US7790144B2 (en) * 2000-01-18 2010-09-07 Mallinckrodt Inc. Receptor-avid exogenous optical contrast and therapeutic agents
AU2001237939A1 (en) * 2000-02-08 2001-08-20 Gulgun Tezel Methods for treating glaucoma
AU2002253795B2 (en) * 2000-11-30 2007-02-01 The Children's Medical Center Corporation Synthesis of 4-Amino-Thalidomide enantiomers
JP4361273B2 (ja) 2001-02-27 2009-11-11 アメリカ合衆国 潜在的な血管形成阻害剤としてのサリドマイド類似体
US20030164219A1 (en) * 2002-02-20 2003-09-04 Joerg Brahm Headliner/duct assembly and welding process therefor
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
US7973057B2 (en) * 2003-09-17 2011-07-05 The United States Of America As Represented By The Department Of Health And Human Services Thalidomide analogs
CA2615231A1 (fr) * 2005-07-15 2007-01-25 Chakshu Research Inc. Procede pour prevenir et traiter des complications ophtalmiques du diabete
US20070066512A1 (en) * 2005-09-12 2007-03-22 Dominique Verhelle Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
US20070173538A1 (en) * 2005-12-23 2007-07-26 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
EP2066174B1 (fr) 2006-09-12 2017-11-08 Beth Israel Deaconess Medical Center, Inc. Compositions contenant de l'alpha-1-antitrypsine et leurs procédés d'utilisation
CN101687042A (zh) * 2007-07-20 2010-03-31 爱尔康公司 用于递送作为受体酪氨酸激酶抑制剂(RTKi)的化合物至眼部的药物制剂
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
JP2024520271A (ja) * 2021-06-06 2024-05-24 スタートン セラピューティクス インコーポレイテッド 治療上有効な量のレナリドミドまたは他の免疫調節剤を投与するための経皮薬物送達システム

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2830991A (en) * 1954-05-17 1958-04-15 Gruenenthal Chemie Products of the amino-piperidine-2-6-dione series
US3025300A (en) * 1955-12-14 1962-03-13 Ciba Pharm Prod Inc New phthalimides and methods for their preparation
US2957872A (en) * 1957-10-21 1960-10-25 Ciba Pharm Prod Inc Phthalimidines and process for manufacturing same
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
US3563986A (en) * 1965-10-12 1971-02-16 Ernst Frankus 4 - phthalimido - n - heterocyclic amino methyl or piperidino hydrazino piperidine diones 2,6
AT278739B (de) * 1966-11-08 1970-02-10 Kwizda Fa F Johann Verfahren zur Herstellung von neuen Anhydriden und Imiden substituierter Dicarbonsäuren
US4067985A (en) * 1972-03-03 1978-01-10 Chemie Grunenthal Gmbh Lactum drug compositions
AR205791A1 (es) * 1972-03-03 1976-06-07 Gruenenthal Chemie Procedimiento de preparacion de sulfobenzo lactamas
US4053615A (en) * 1972-10-21 1977-10-11 John Wyeth & Brother Limited Phthalimidopiperidines and anti-convulsant compositions thereof
IL47062A (en) * 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
US4067085A (en) * 1976-02-09 1978-01-10 Gasbarro Geno N Automatic poultry cutting apparatus
US4461619A (en) * 1981-12-29 1984-07-24 Medical College Of Georgia Research Inst. Method of predicting biological activity of compounds by nucleic acid models
DE3619303A1 (de) * 1986-06-07 1987-12-10 Merck Patent Gmbh Optisch aktive adsorbentien
US4800162A (en) * 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
US5079152A (en) * 1987-05-28 1992-01-07 Scripps Clinic And Research Foundation Antibody combining sites that exhibit stereoselective synthase activity, and methods using the same
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5057427A (en) * 1988-04-07 1991-10-15 Sepracor, Inc. Method for resolution of stereoisomers
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5104899A (en) * 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
US5120720A (en) * 1990-09-20 1992-06-09 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
US5114715A (en) * 1990-11-29 1992-05-19 Sepracor Inc. Methods of use and compositions of (s)-isoflurane and (s)-desflurane
US5443824A (en) * 1994-03-14 1995-08-22 Piacquadio; Daniel J. Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions

Also Published As

Publication number Publication date
US5443824A (en) 1995-08-22
WO1995024891A1 (fr) 1995-09-21
US5605684A (en) 1997-02-25

Similar Documents

Publication Publication Date Title
AU1997795A (en) Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
AU5703798A (en) Topical anti-acne composition
AU3254495A (en) Highly bioadhesive and mucoadhesive compositions for the treatmenof epithelia and mucous membranes
AU5913794A (en) Preserved wet wipes
AU1850295A (en) Adhesive free topical pharmaceutical formulations
AU4023095A (en) Composition having wet state clarity
AU2215995A (en) Freeze-dried compositions comprising rna
AU5203098A (en) Nail enamel composition
ZA975902B (en) Topical composition
AU3308195A (en) Antihypertriglyceridemic composition
AU4254596A (en) Cosmetic composition
AU5988896A (en) Topical composition for fungal treatment
ZA949250B (en) Topical anti-inflammatory compositions containing piroxicam
AU2905597A (en) Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics
AU7888498A (en) Carcinogenesis inhibitors
AU3726395A (en) Improved topical carriers for mucosal applications
AU2310395A (en) Topical retinal-based composition
AU4056597A (en) Topical composition for burn healing
AU2953497A (en) Topical composition
AU1876797A (en) Topical formulations for the treatment of nail psoriasis
AU1658997A (en) Topical composition
AU2728295A (en) Cat-food dressing
AUPM500494A0 (en) Composition for use in increasing mucosal immunity
AU5567099A (en) Cosmetic compositions for topical applications
AU2967797A (en) Topical pediculicidal compositions